14 articles for SD Knight
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a Potent Class of PI3Ka Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT).
Glaxosmithkline
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.
Glaxosmithkline
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.
TBA
Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
Glaxosmithkline
Signaling function of PRC2 is essential for TCR-driven T cell responses.
The Rockefeller University
Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.
Cytokinetics Inc
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.
GlaxoSmithKline
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.
Smithkline Beecham Pharmaceuticals
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
Xw Laboratories
Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
Bristol-Myers Squibb
Design, synthesis, biological screening, and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for the treatment of type 2 diabetes.
Csir-Central Drug Research Institute